The objective of this review was to describe the epidemiology and risk factors of prostate cancer (PCa) in Asian populations. English language publications published over the last 10 years covering studies on the incidence, mortality, and risk factors of PCa in Asia were reviewed. The incidence of PCa in Asia is rising but is still significantly lower than that in Western countries. Studies in Asia indicated that the consumption of red meat, fat, dairy, and eggs was associated with a higher risk for PCa. Age and family history were also found to be risk factors. The emergence of genetic data indicates that different genetic backgrounds between Asian and Western populations play a role in the observed differences in PCa incidence. The lower incidence of PCa in Asian men than in Western men may in part be due to a lack of systematic prostate-specific antigen screening, but environmental and genetic factors also play a role.
Introduction
Prostate cancer (PCa) is the second most prevalent cancer in men worldwide 1 . However, large variations in incidence rates exist between geographical regions, with a 25-fold difference between countries with the highest and lowest incidence rates 2 . There were 307,000 deaths from PCa in 2012, and it is the fifth leading cause of death in men globally. There is relatively less variation in mortality rates worldwide (10-fold variation from approximately 3 to 30 per 100,000). 1 The mortality rates have been declining in many developed countries in part because of improved treatment. The incidence of PCa in Asian countries remains significantly lower than in Western countries. 1 The highest estimated age-specific rate of PCa incidence occurs in Australia/New Zealand and Northern America (age-specific rate 111.6 and 97.2 per 100,000, respectively) compared to an estimated rate of 10.5 in Eastern Asia, 11.2 in Southeast Asia, and 4.5 in South Central Asia. 1 However, the incidence and mortality of PCa is rising in several Asian countries. 1, 2 There is a lack of detailed information about the burden of PCa in Asia, which is geographically, ethnically, and economically diverse.
A better understanding of the epidemiology of PCa within Asia, including its modifiable and nonmodifiable risk factors, may facilitate better health-care decision and policymaking. The objective of this review of English language publications from the last 10 years is to describe the epidemiology, incidence, mortality, and risk factors of PCa in Eastern, Southeast, and South Central Asian populations and compare with data from Western countries.
Methods
Eligible articles were identified via a search of PubMed. Published journal articles were eligible for inclusion in this review if they involved participants of any age with PCa of any histopathology, grade, and stage, where their PCa could be of any receptor, molecular, or genetic status; examined at least one of the following outcomes: PCa epidemiology, prevalence, incidence, and risk factors; were written in English; published in the last 10 years (January 2006 to September 2017); and reported data on human individuals from Asia. Medical subject headings were used to generate a search string that was used in the PubMed search (see supplementary information for further details).
Article selection was performed in a manual nonblinded manner by a single person. Articles were excluded if their primary objective was to either examine the correlation of PCa with other types of cancer or to examine surgical treatments for PCa. No methods were used to assess the risk of bias in individual studies or across studies, and no meta-analyses were performed.
The methods used for the calculation of incidence and mortality rates that are reported in the Results section are detailed in the references associated with the reported data. Asia   Table 1 summarizes studies that have investigated the incidence and mortality of PCa in Asia. These studies provide evidence that the incidence of PCa is increasing in China, 3 India, 4,5 South Korea, 6, 7 Vietnam, 8 Japan, 9 and Singapore. 10, 11 The increase in incidence is also supported by data from Globocan from 2008 and 2012, shown in Table 2 , which show that PCa incidence has risen in all areas of Asia in this time.
Results

PCa epidemiology in
1,2 Table 3 shows the incidence and mortality data for 2012 for six countries in Asia. 12 The incidence and mortality vary significantly across Asia. Many studies observed that the agespecific incidence rates increased with increasing age. 4, 10, 13, 14 The trends observed in PCa mortality rates in Asian studies were more variable. Tseng 15 observed an increase in mortality in the that although there appeared to be a general decrease in PCa mortality from 2000 to 2009 in Shanghai, China, the trend was not significant. Globocan data showed an increase in mortality rates across Asia, whereas in North America and Australia, the mortality rates had remained stable or declined.
1,2
The incidence rate in North America was up to 20 times greater than the incidence rate in Asia. However, the mortality rate was only around 2.5 times the rate in Asia. 1 The mortality rate to incidence rate ratio (MR/IR) can give an indirect index for the evaluation of survival and early diagnosis. 18 In 2012, the MR/IR was 0.1 in America, 0.18 in Europe, and 0.25 worldwide, whereas in Asia, this ratio ranged from 0.3 up to 0.6. 1 The high MR/IR ratio may be due to the diagnosis of PCa at a later stage in Asia than in Western countries. There is evidence that patients are often diagnosed with late stage disease in Asia. 
Modifiable risk factors
An increased incidence of PCa for Asian immigrants in Western countries compared to their native counterparts 22 suggests that environmental factors may play an important role in the prevention of PCa. Table 4 outlines the modifiable risk factors that have been investigated in various Asian studies; Supplementary Table 1 provides further details including the countries in which the studies were conducted. There were often contradictory findings for the various risk factors which could in part be due to differences in study design.
Dietary factors
The dietary factors in PCa may have an influence on circulating androgens and estrogens or as a general protective effect against mitogens. 23 3.2.1.1. Meat, fat, eggs, and dairy products. A high intake of red meat, fat, dairy products, and eggs was found to be associated with an increased risk of PCa.
24e29 Meat is rich in saturated fat and cholesterol, and dairy products are also rich in saturated fats. However, this does not necessarily imply that animal fat is a risk factor for PCa. Other aspects need to be considered. For example, high levels of red meat consumption may also mean a lower consumption of plant foods. Dairy products also contain calcium and other substances such as zinc that may have an association with increased PCa risk. 23 The manner in which food is prepared is also another important consideration. 23 The consumption of meat and dairy products has significantly increased in Asia over recent years but is still lower than the amount consumed in Western countries. 29 found that the consumption of fish significantly increased the risk of PCa, whereas a Japanese study 35 found that a high intake of fish may be inversely associated with the risk of PCa death. It is thought that the presence of omega-3 fatty acids in fish may reduce the risk of PCa. However, in these studies, the type and amount of fish consumed was not assessed which may help explain the difference in study results.
Green tea.
Green tea is a popular beverage in Asia and contains epigallocatechin-3-gallate (EGCG), an antioxidant that may play an important role in cancer prevention. Kurahashi et al 36 found that the consumption of green tea (3 to 4 cups per day to greater than 5 cups/day) was associated with a decreased risk of advanced PCa, and Jian et al 37 observed that PCa risk was reduced with increased consumption of green tea. However, several studies found no association between the consumption of green tea and the risk of PCa 38, 39 . The contradictory findings may in part be due to differences in study design, misclassification of results due to baseline assessments, or differences in how the tea was brewed.
3.2.1.5. Soy products. Soy products are commonly found in traditional Chinese and Japanese diets, and there is some evidence that isoflavones found in soy products, such as genistein and daidzein, effect oestrogen and testosterone metabolism and exhibit anticarcinogenic properties 32, 40 . Li et al 41 found that the consumption of soy products (either more than twice a week or more than once a day) resulted in a protective effect against PCa. Nagata et al 42 found
that total isoflavones, genistein and daidzein, were significantly associated with decreased risk of PCa. Kurahashi et al 40 found that although the consumption of genistein, daidzein and other isoflavones resulted in a decrease in the risk for localized PCa, they tended to increase the risk of advanced PCa.
Obesity and physical exercise
Masuda et al 43 found a significantly increased risk of PCa and high-grade disease at biopsy among obese and overweight men in Japan. A study in Pakistan 25 also found an increased risk for PCa for obese men with a body mass index>25. However, other studies have found no association with body mass index and risk of 25 found that moderate physical exercise reduced the risk of PCa. However, the level of physical activity in the study was poorly defined. The contradictory results may be due to different study designs or a lack of statistical power due to a low frequency of obesity.
Tobacco and alcohol
Smoking may increase the risk of PCa as it is known to affect steroid levels and to contain multiple carcinogens. 45, 46 However, the findings for tobacco smoking were contradictory. Several studies found no association between smoking and the risk of PCa, 24,45e47 whereas studies in Pakistan and North India found that smoking increased the risk of PCa. 25, 34 Although two studies in India and China did find an increased risk of PCa associated with alcohol consumption, 29, 48 other studies found no association between alcohol consumption and the risk of PCa. 24, 34, 45 The association of PCa with alcohol may be dose dependant. Light alcohol consumption may be antiinflammatory and antiandrogenic, whereas heavy alcohol intake may increase inflammatory responses or alter sex hormone levels. 45 In the study by Subahir et al, 24 the maximum mean alcohol consumption was two times per day, and this may be one reason why no association was observed.
Nonmodifiable risk factors
Nonmodifiable risk factors encompass both physiological risk factors, such as age, ethnicity, and family history, and genetic factors, such as gene mutations and chromosomal, gene, or single nucleotide polymorphisms (SNPs). 
Testosterone levels
The responsiveness of PCa to hormonal therapy supports the view that testosterone might play an important role in the pathogenesis of PCa. 50 However, results from two studies in China and South Korea regarding the association of levels of testosterone and PCa risk were unclear. Dai et al 51 found that total testosterone levels were lower in patients with high-grade disease. Hong et al 50 observed no association between testosterone levels and PCa.
Diabetes
Studies have shown an association between diabetes and cancer in Western countries, 52 although the precise underlying biological mechanism remains speculative. 32 Studies in Taiwan and Japan showed that patients with diabetes were reported to have a higher risk for PCa than nondiabetic patients. 15 ,52e54 A study that conducted a pooled analysis from 19 Asian cohorts found that type 2 diabetes was associated with an increased risk of death from PCa. 55 The use of metformin (a biguanide antihyperglycemic agent) was observed to reduce the risk. 56 A study in South Korea found that higher fasting serum glucose levels were positively related to PCa susceptibility risk. 57 The influence of insulin on the risk of PCa was unclear. A study in Nepal reported that high insulin levels were associated with an increased risk for PCa when compared to fasting levels ( 2.75 mU/mL). 58 Separately, a Taiwanese study reported that exposure to human insulin had no effect on the risk of PCa, 59 and a South Korean study reported that higher serum insulin levels were inversely related to PCa susceptibility risks. 57 It has been reported in a Japanese study that insulin growth factor (IGF)-1 was not significantly associated with PCa, whereas IGF-2 and IGF-binding protein 3 (IGFBP-3) showed weak, nonstatistically significant associations. 44 A study in South Korea 50 also found no significant Consumption of fruits and vegetables, green tea; genistein, daidzein, and isoflavone (in soy foods; localized PCa) 29, 30, 33, 34, 36, 37 Overweight and obesity 25, 43 Overweight and obesity 42, 44, 45 Physical exercise 25 Physical exercise 42 Tobacco smoking; past smokers only 25, 29, 34 Tobacco smoking 24,27,45e47,96 Alcohol consumption 29, 48, 96 Alcohol consumption 24 ,27,34,45 correlation between serum levels of IGF-1 and IGFBP-3 with known prognostic parameters of PCa.
Genetic factors
A study in Sweden found that Asian immigrants had significantly lower PCa risk than native Swedes and that older age at immigration and a recent immigration history were significantly associated with lower PCa risk. 60 Lee et al 22 found that Korean immigrants living in America had a lower rate of PCa than black and white Americans but that PCa was higher in Korean Americans than in their native counterparts. They also observed that there had been a 71% increase in incidence rate of PCa for Korean Americans from 1988 to 2002. McCracken et al 61 found that the incidence and mortality rate of PCa for five different Asian ethnic groups in California was lower than for non-Hispanic white men. Furthermore, groups with older immigration histories, such as Japanese and Filipinos, had a higher incidence and mortality rate than groups with more recent immigration histories. One reason for the large difference in PCa incidence between Asian and Western countries may be due to different genetic backgrounds. Various genome-wide association studies have been carried out in Asia to identify genetic markers associated with PCa risk. Of the genetic risk factors studied, polymorphisms in the various genes of cytochrome P450 appear to be inextricably linked to the risk for PCa, 62e69 and a number of polymorphisms at the 8q24 region of chromosome 8 have also been identified as PCa risk factors. 70e75 In addition, the predictive potential of a number of PCa riskeassociated single nucleotide polymorphisms (SNPs) for PCa in Chinese, Malaysian, and Japanese men has been reported.
27,76e79 European populations. The three studies identified that 7, 11, and 17 PCa riskeassociated SNPs were replicated in Asian populations that were initially discovered from genome-wide association studies of European descent. A number of the same SNPs were identified across the three studies ( Table 6 ). The prevalence of TMPRSS2-ERG fusion and PTEN inactivation in Asians may be approximately half that of Caucasians. 80 
Discussion
Over the last 10 years, PCa incidence rates have steadily increased in a number of Asian countries, although the overall incidence rates for PCa in Asia continue to remain far below that for Western countries. The lack of systematic prostate screening programs in many countries in Asia may partly explain the lower incidence. However, Asian immigrants in the United States and Western Europe, who should have better access to prostate-specific antigen screening, still show a lower incidence of PCa than the native population living in the same regions.
The small value for MR/IR in North America and Europe may provide evidence that vigorous annual screening with prostatespecific antigen reduces PCa mortality. 18 In comparison, survival rates are poor in Asian countries, and the lack of routine screening in Asia has been attributed to the diagnosis of the disease at later stages compared to Western countries. 19 Studies of prostate screening programs in Japan found that there was an inverse correlation between the exposure rate to population screening and the proportion of advanced PCa. 81 There is resource and economic variation within Asian countries compared to Western countries. Use of metformin to treat diabetes and high insulin levels 56 Insulin growth factor (IGF)-1, IGFBP-3, insulin level 44, 50, 59 Korean Americans compared to native Koreans and older immigration history 22, 60 First-generation immigrants to Sweden compared to Swedish-born men; Asian ethnic group in California compared to non-Hispanic white men. 60, 61 Various P450 polymorphisms 62e69 and polymorphisms at the 8q24 region 70e75 Access to health care and resource availability may be other factors that affect both the incidence and mortality of PCa in Asia. 82 The findings obtained for modifiable risk factors for PCa in Asia indicate that environmental exposures probably play a major role, although the only identified factors associated with higher risk of PCa were high consumption of red meat, fat, dairy products, and eggs. These findings are in line with data from studies carried out in Europe and America which found that frequent consumption of dairy products and meat may enhance PCa risk. Similar to the studies carried out in Asia, the data from Western countries for preventative behavioural factors were not entirely consistent. 32 A lack of robust data on potentially modifiable factors means that there are no immediate prospects for population-based primary or secondary prevention strategies focused on altering diet or lifestyle. 32, 83 In line with findings in Western countries, age and family history were nonmodifiable risk factors for PCa. 32 There is little doubt that testosterone plays an important role in the development of PCa. However, there have been inconsistent findings on the relationship between testosterone and PCa. 84 Various investigators have suggested that racial variations in serum levels of hormones, including testosterone along with its derivatives, exist and that hormonal differences might contribute to differences in PCa risks among different races. 85 Han et al 63 suggest that it is the agerelated declines in testosterone levels that are significant to the genesis of PCa and not just the level at a single point in time, which could explain the inconsistent findings.
The association between diabetes and PCa has also been inconsistently reported. Some findings from studies with Caucasian men indicate that the risk of PCa may have an inverse relationship with diabetes. 83, 86 Turner et al 83 suggest that the stage of diabetes may be important. Higher concentrations of insulin and -IGF-1 are positively associated with PCa and are found in early diabetes, whereas lower insulin and IGF-1 levels occur in long-standing diabetes. 83 Studies carried out in Asia indicated that there was a link between diabetes and PCa in Asian men. 15,52e54,86 Furthermore, the finding that metformin (which generally works by reducing levels of both circulating glucose and insulin 87 ) reduced PCa risk and that elevated serum glucose levels increased the risk of PCa support an association between diabetes and PCa. The influence of genetics on incidence of PCa has been well supported by epidemiologic studies of immigrant populations 22, 60, 61 . Ewis et al 88 In summary, we have provided a review of the available data on the epidemiology of PCa in Asia from the last 10 years, and a number of potential risk factors for PCa in Asian populations have been identified.
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